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Abstract: Two sponge-derived actinomycetes, Actinokineospora sp. EG49 and 
Nocardiopsis sp. RV163, were grown in co-culture and the presence of induced 
metabolites monitored by 
1
H NMR. Ten known compounds, including angucycline, 
diketopiperazine and β-carboline derivatives 1–10, were isolated from the EtOAc extracts 
of Actinokineospora sp. EG49 and Nocardiopsis sp. RV163. Co-cultivation of  
Actinokineospora sp. EG49 and Nocardiopsis sp. RV163 induced the biosynthesis of three 
natural products that were not detected in the single culture of either microorganism, 
namely N-(2-hydroxyphenyl)-acetamide (11), 1,6-dihydroxyphenazine (12) and 
5a,6,11a,12-tetrahydro-5a,11a-dimethyl[1,4]benzoxazino[3,2-b][1,4]benzoxazine (13a). 
When tested for biological activity against a range of bacteria and parasites, only the 
phenazine 12 was active against Bacillus sp. P25, Trypanosoma brucei and interestingly, 
against Actinokineospora sp. EG49. These findings highlight the co-cultivation approach as 
an effective strategy to access the bioactive secondary metabolites hidden in the genomes 
of marine actinomycetes. 
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1. Introduction 
The search for novel biologically active natural products sourced from marine microbes continues 
to be an important endeavour fuelled by the emergence of new infections diseases and chemotherapy 
resistance. Marine-derived actinomycete collections have recently yielded new compounds with not 
only potent biological activity, but also novel molecular scaffolds, for example salinosporamide A [1] 
and marinopyrroles A and B [2]. Salinosporamide A was shown to be an irreversible inhibitor of the 
20S proteasome and entered clinical trials against multiple myeloma, only three years after its 
discovery [3]. However, finding new microbial secondary metabolites is becoming difficult, as the rate 
of rediscovery of known compounds is increasing [4,5]. On the other hand, genomic sequencing has 
revealed the presence of a large number of putative biosynthetic gene clusters in the genomes of some 
microorganisms that encode for secondary metabolites that are not seen under classical cultivation 
conditions [6–8]. Different strategies have been proposed to activate these cryptic biosynthetic 
pathways. Co-fermentation of microorganisms in a single environment is one of the proposed methods 
to de-silence biosynthetic pathways for the production of new secondary metabolites [7,9–11]. Mixed 
fermentation of two or more microbes can make a competitive environment, which may induce 
unexpressed pathways and result in the synthesis of bioactive secondary metabolites due to 
interspecies crosstalk or chemical defence mechanisms [11–13]. 
Examples of the production of induced new natural products by mixed fermentation of  
marine-sourced microorganisms include a chlorinated benzophenone pestalone [14] sourced from 
Pestalotia sp. strain CNL-365 and marine α-proteobacterium strain CNJ-328, the diterpenoids 
libertellenones A–D isolated from a co-culture of the same bacterial strain CNJ-328 with the fungus, 
Libertella sp. CNL-52 [15], and cyclic depsipeptides emericellamides A and B isolated from a  
co-culture of marine-derived fungus Emericella sp. (CNL-878) and marine bacterium Salinispora 
arenicola [16]. In this work, we focus on the induced metabolites from the co-cultivation of two 
sponge-sourced actinomycetes. Several in-house strains were co-cultured and the presence of 
differential secondary metabolite production monitored by UV-Vis, MS and NMR techniques.  
Two strains, namely Actinokineospora sp. and Nocardiopsis sp., when grown in co-culture showed 
different chemical profiles to that of the mono-cultures and were prioritised for large-scale natural 
product isolation work. 
Members of the genus Actinokineospora were isolated from soil, plants [17,18] and marine  
sponges [19]. Although this genus is not well known for secondary metabolite production, we recently 
reported two new angucycline-like compounds named actinosporins A (1) and B (2) from 
Actinokineospora sp. EG49, where actinosporin A displayed anti-parasitic activity against 
Trypanosoma brucei brucei [20]. On the other hand, the genus, Nocardiopsis, is frequently isolated 
from terrestrial, as well as marine environments, including marine sponges [21–23]. Members of this 
genus are prolific producers of a multitude of secondary metabolites with diverse activities [24–27].  
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In this study, two sponge-derived actinomycetes were co-cultured in liquid media; these being 
Nocardiopsis sp. RV163 from the Mediterranean sponge Dysidea avara, and Actinokineospora sp. 
EG49 from the Red Sea sponge, Spheciospongia vagabunda. To the best of our knowledge, this is the 
first report of induced metabolites from the mixed fermentation of two sponge-associated actinomycetes. 
Traditionally, the detection of induced metabolite biosynthesis has relied either on LC-PDA [5,28,29] or 
LC-PDA-MS [12,15,16,30], methods to monitor the production of the secondary metabolite by 
comparison of the small molecule profiles of the mono- and co-cultures of microorganisms. However, 
these analytical techniques are dependent either on the existence of a chromophore (PDA detection) or 
the ability of a compound to be ionised (MS detection) and might not detect all of the changes of the 
secondary metabolome between the mono- and co-cultures. In order to further interrogate the existence 
of the induced change in the secondary metabolome profiles, we used LC-PDA, as well as 
1
H-NMR 
fingerprinting techniques. Following the detection of the production of the induced metabolites, an 
isolation process was performed, which led to the identification of N-(2-hydroxyphenyl)-acetamide 
(11), 1,6-dihydroxyphenazine (12) and 5a,6,11a,12-tetrahydro-5a,11a-dimethyl[1,4]benzoxazino[3, 
2-b][1,4]benzoxazine (13a). 
2. Results and Discussion 
The mono- and co-culture secondary metabolite profiles were monitored with a combination of  
UV-PDA and NMR-based spectroscopic techniques. Figure 1 depicts the LC-PDA metabolic profile of 
the three actinomycetes cultures and shows that the co-culture extract displayed a very different 
chemotype compared to that of the two single cultures. In order to further investigate the differences of 
the secondary metabolite profiles by 
1
H-NMR and to have a sufficient quantity to identify the 
metabolites, a large-scale study was undertaken on 50 mg of the EtOAc extract. The methodology 
utilised identical reversed-phase C18 stationary support as for the analytical HPLC run, but allowed for 
a longer elution gradient, which gave better sensitivity and resolution of the secondary metabolites 
present. 
1
H-NMR spectra were then used to compare the differences between each chromatography 
fraction sourced from the mono- and co-cultures. 
2.1. Monoculture Chemical Profiles 
Previously, we reported on the structures of two new angucycline-type metabolites, actinosporins A 
(1) and B (2) (Figure 2), isolated from Actinokineospora sp. EG49 [20]. In this work, compounds 1 and 
2 were confirmed to be the major metabolites present in this extract, and further attempts at the 
structure elucidation of minor metabolites were not made. The majority of the natural products present 
in the EtOAc extract of Nocardiopsis sp. RV163 belonged to the diketopiperazine class of compounds. 
They were identified as 2,5-diketopiperazines cyclo-(prolyl-valyl) (3) [31], cyclo-(isoleucyl-prolyl)  
(4) [32], cyclo-(leucyl-prolyl) (5) [31], cyclo-(prolyl-tyrosyl) (6) [33], cyclo-(phenylalanyl-prolyl)  
(7) [32] and cyclo-(prolyl-tryptophyl) (8) [34,35]. The purity of the compounds (at <90%) prevented 
us from confirming the absolute configuration of the diketopiperazines, 3–8. Two other secondary 
metabolites in Nocardiopsis sp. RV163 EtOAc extract were identified as known natural products  
1-hydroxy-4-methoxy-2-naphthoic acid (9) [36] and 1-acetyl-β-carboline (10) [37]. 
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Figure 1. HPLC chromatograms of the EtOAc extracts of Actinokineospora sp. EG49 and 
Nocardiopsis sp. RV163 co-culture (top), Actinokineospora sp. EG49 monoculture 
(middle) and Nocardiopsis sp. RV163 monoculture (bottom). The depicted 
chromatograms were extracted at 210, 254, 280 and 380 nm, and the bottom two spectra 
show representative examples of the natural products isolated from the two strains. 
 
Figure 2. The structure of the major compounds identified from the EtOAc extracts of 
Actinokineospora sp. EG49 actinosporins A (1) and B (2); Nocardiopsis sp. RV163  
cyclo-(prolyl-valyl) (3), cyclo-(isoleucyl-prolyl) (4), cyclo-(leucyl-prolyl) (5),  
cyclo-(prolyl-tyrosyl) (6), cyclo-(phenylalanyl-prolyl) (7), cyclo-(prolyl-tryptophyl) (8),  
1-hydroxy-4-methoxy-2-naphthoic acid (9) and 1-acetyl-β-carboline (10); and the  
co-culture, N-(2-hydroxyphenyl)-acetamide (11), 1,6-dihydroxyphenazine (12), 
5a,6,11a,12-tetrahydro-5a,11a-dimethyl-1,4-benzoxazino[3,2-b][1,4]benzoxazine (13a) 
and 2,2′,3,3′-tetrahydro-2,2′-dimethyl-2,2′-bibenzoxazole (13b). 
 
Mar. Drugs 2014, 12 3050 
 
 
2.2. Co-Culture Chemical Profile 
Having established the UV-PDA, MS and the 
1
H-NMR profile of the two monocultures, the  
co-culture extract was investigated. The 
1
H-NMR spectra of the same chromatography fractions of 
mono- and co-culture extracts were compared, and since the retention times of compounds can vary, 
the neighbouring fractions were also considered. The presence of the first induced metabolite was 
apparent in the 
1
H-NMR spectra of fraction 5 of co-culture compared to that of the mono-cultures. 
Aromatic signals in the region 6.70 to 7.70 ppm were observed in co-culture that were not present in 
the spectra of the Actinokineospora sp. EG49- and Nocardiopsis sp. RV163-sourced fractions  
(Figure 3a). The absence of these NMR signals in both monocultures suggested that this was an 
induced metabolite produced through mixed fermentation of the two actinomycetes. A literature search 
based on the molecular ion and structural information generated from the 
1
H-NMR spectrum identified 
this compound to be the known natural product, N-(2-hydroxyphenyl)-acetamide (11) [38]. 
Figure 3. 
1
H-NMR fingerprints of HPLC fractions sourced from the EtOAc extracts of 
Actinokineospora sp. EG49 and Nocardiopsis sp. RV163 co-culture (top in black), 
Actinokineospora sp. EG49 monoculture (middle in blue) and Nocardiopsis sp. RV163 
monoculture (bottom in red). (a) 
1
H-NMR spectra of fraction 5; chemical shifts for the 
induced metabolite N-(2-hydroxyphenyl)-acetamide (11) are highlighted; (b) 
1
H-NMR 
fingerprints of fraction 24; the possible presence of compound 12 in the Actinokineospora 
sp. EG49 monoculture is highlighted. 
 
In addition to fraction 5, two other chromatography fractions showed the presence of induced 
metabolites. In regions concentrated around fraction 24, aromatic signals between 7.15 and 7.80 ppm 
and an exchangeable one at 10.45 ppm were detected in co-culture, and while initially this compound 
was not apparent in either of the two monocultures, the 
1
H-NMR fingerprint suggested that this 
metabolite may be present in very small amounts in the Actinokineospora sp. EG 49 extract  
(Figure 3b). In order to further interrogate whether compound 12 was present in the Actinokineospora sp. 
EG49 monoculture extract, we performed an NMR titration experiment (see Supplementary Information). 
NMR-detected titration of pure 12 into fraction 24 sourced from the Actinokineospora sp. EG49 extract 
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demonstrated that compound 12 was not present in the mono-culture sample and confirmed that this 
small molecule is another induced metabolite from the mixed fermentation experiment. Based on the 
comparison of the mass and the NMR information with the literature, the induced metabolite was 
identified to be 1,6-dihydroxyphenazine (12) [39]. Compound 12 was produced in a very high yield 
(12% crude weight), and being in such a high abundance we found that this major component was 
present in the NMR fingerprints of many of the consequent fractions of the co-culture extract. 
Fractions 26 and 27, in addition to having 
1
H-NMR signals of 1,6-dihydroxyphenazine, showed 
additional proton signals in the aromatic region, which were not present in either of the monoculture 
extracts (for the NMR fingerprint comparison, see Supplementary Information). The spectroscopic  
and spectrometric data of the third induced metabolite were consistent with the structures of 
5a,6,11a,12-tetrahydro[1,4]benzoxazino[3,2-b][1,4]benzoxazine (13a) and 2,2′,3,3′-tetrahydro-2, 
2′-dimethyl-2,2′-bibenzoxazole (13b) (Figure 2). Both compounds have previously been reported  
as the condensation product of 2-propyn-1-ol and dibenzo-2-amino alcohol, with the cis-fused 
benzoxazino-benzoxazine structure, 13a, confirmed as the correct product via single crystal X-ray 
analysis [40]. In this work, an insufficient amount of the compound has been isolated to provide a good 
quality crystal for an X-ray, and the assignment was based on NMR data. However, in contrast to 
[2,2′]bifuranyl-pyranopyran models [41], the 13C chemical shifts of the ring fusion atoms in 13a and 
13b do not provide the distinction of the ring size [42]. Based on the literature evidence of compound 
13a being the major isomer in solution [43], we propose the structure of the induced natural product  
to be 5a,6,11a,12-tetrahydro-5a,11a-dimethyl[1,4]benzoxazino[3,2-b][1,4]benzoxazine (13a). Since 
this is the first report of compound 13a as a natural product, a complete set of NMR data is given  
in pyridine-d5. 
In addition to tracking the production of the induced metabolites in the co-culture extract, the NMR 
experiment was also useful in showing the suppression of the production of some natural products. For 
example, while in Figure 3b, the main compound in fraction 24 sourced from the Actinokineospora sp. 
EG49 crude extract is actinosporin B (2) (blue, middle spectrum), in the co-culture NMR spectrum 
(black, top spectrum), all resonances for compound 2 are missing, indicating that the mixed 
fermentation suppressed the production of actinosporin B. In support of the NMR observations, the 
mixed culture of the two microbes was dominated by the Nocardiopsis sp. RV163, which is 
characterized by large brown colonies and the production of spores, while very little growth was 
observed by the yellow cells of the Actinokineospora sp. EG49. 
2.3. Anti-Infective Activity of Induced Metabolites 
The three induced compounds, N-(2-hydroxyphenyl)-acetamide (11), 1,6-dihydroxyphenazine (12) 
and 5a,6,11a,12-tetrahydro-5a,11a-dimethyl[1,4]benzoxazino[3,2-b][1,4]benzoxazine (13a), were 
tested for their activities against Bacillus sp. P25, Escherichia coli and Fusarium sp. P21, human 
parasites Leishmania major and Trypanosoma brucei, as well as Nocardiopsis sp. RV163 and 
Actinokineospora sp. EG49 cultures. Biological activity was documented for compound 12 against 
Bacillus sp. (11 mm inhibition zone diameter), Trypanosoma brucei (IC50 value of 19 μM) and, 
interestingly, against Actinokineospora sp. EG49 (15 mm inhibition zone diameter) (see 
Supplementary Information). 
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3. Experimental Section 
3.1. General Experimental Procedures 
Optical rotations were measured on a JASCO P-1020 polarimeter with a 10-cm cell. UV spectra 
were acquired on a Jasco V650 UV/vis spectrophotometer. A Jasco J-715 spectropolarimeter was used 
to record circular dichroism spectra. NMR spectra were recorded at 30 °C on a Varian Inova 600 MHz 
spectrometer equipped with a triple resonance 5-mm cold probe. For NMR fingerprint experiments, the 
samples were dissolved in 230 μL of DMSO-d6 and run in a 3-mm NMR tube. The standard VnmrJ 3.2 
Proton pulse sequence was run with the following parameters: pw = 45°, p1 = 0 μs, d2 = 0 s, d1 = 1 s, 
at = 1.7 s, sw = 9615 Hz, nt = 8 scans. LC-MS spectra were obtained using a Waters ZQ electrospray 
mass spectrometer with a Phenomenex Luna C18 column (4.6 mm × 50 mm, 3 μm) (Phenomenex, 
Torrance, CA, USA). Analytical HPLC was done with a Phenomenex Onyx Monolithic C18 column 
(4.6 × 100 mm) (Phenomenex, Torrance, CA, USA). A Phenomenex Onyx Monolithic C18 column 
(10 mm × 100 mm) (Phenomenex, Torrance, CA, USA) was used for semi-preparative HPLC 
separation. All HPLC and LC-MS experiments were performed with a MeOH-H2O gradient solvent 
system. Millipore Milli-Q PF filtered H2O and HPLC grade solvents were used for chromatography. 
3.2. Microbial Fermentation and Extracts Preparation 
Nocardiopsis sp. RV163 was isolated from the Mediterranean sponge, Dysidea avara, while 
Actinokineospora sp. EG49 was cultivated from the Red Sea sponge, Spheciospongia vagabunda [19]. 
Each strain was fermented in 8 Erlenmeyer flasks (2 L), each containing 1 L of ISP 2 (International 
Streptomyces Project) medium in artificial sea water and incubated at 30 °C for 7 days with shaking at 
150 rpm. For co-cultivation experiment, 10 mL of 5-day-old culture of Nocardiopsis sp. RV163 was 
inoculated into 8 Erlenmeyer flasks (2 L), each containing 1 L of ISP 2 medium inoculated with 10 mL 
of 5-day-old culture of Actinokineospora sp. EG49. After fermentation of single cultures and  
co-culture, filtration was done, and the supernatant was extracted with ethyl acetate (2 × 500 mL) to 
give the ethyl acetate extract. XAD16 resin was then added to the mother liquor, shaken, filtered and 
finally extracted with acetone (acetone extract). The cells and mycelia were macerated in a double 
volume of methanol with shaking for 3 h, then filtered (methanolic extract). 
3.3. Extraction and Isolation 
3.3.1. General Chromatographic Procedures for Large-Scale Isolation and Fingerprinting Work 
Crude extract (50 mg) was chromatographed using HPLC on a semi-preparative Phenomenex Onyx 
Monolithic reversed-phase C18 column (10 mm × 100 mm). Initially, isocratic conditions of 10% MeOH 
were used for 10 min, then a linear gradient from 10% to 100% MeOH was performed over 40 min 
and continued isocratically for 10 min at a flow rate of 9 mL/min. Sixty fractions collected in 
one minute increments over 60 min were dried for NMR and mass studies. 
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3.3.2. Actinokineospora sp. EG49 
EtOAc extract (50 mg) was pre-adsorbed to C18-bonded silica and then packed into a stainless steel 
HPLC guard cartridge (10 × 30 mm) that was subsequently attached to a C18 HPLC column. Standard 
gradient conditions described above were employed to give actinosporin B (10) in fraction 24 and 
actinosporin A (1) in fraction 31. 
3.3.3. Nocardiopsis sp. RV163 
EtOAc extract (50 mg) was pre-adsorbed to C18-bonded silica and then packed into a stainless steel 
HPLC guard cartridge (10 × 30 mm) that was subsequently attached to a C18 HPLC column. Standard 
gradient conditions described above were employed. Fraction 9 was a mixture of cyclo-(prolyl-valyl) 
(3), cyclo-(isoleucyl-prolyl) (4) and cyclo-(leucyl-prolyl) (5). Semi-pure cyclo-(prolyltyrosyl) (6) (1.6 mg) 
and cyclo-(phenylalanyl-prolyl) (7) (1.0 mg) were identified from fractions 15 and 16, respectively, cyclo 
(prolyl-tryptophyl) (8) was identified from fraction 17. 1-hydroxy-4-methoxy-2-naphthoic acid (9)  
(0.7 mg) and 1-acetyl-β-carboline (10) (0.2 mg) were identified in fractions 26, 27 and 30, respectively. 
3.3.4. Actinokineospora sp. EG49 and Nocardiopsis sp. RV163 Co-Culture 
EtOAc extract (50 mg) was pre-adsorbed to C18-bonded silica and then packed into a stainless steel 
HPLC guard cartridge (10 × 30 mm) that was subsequently attached to a C18 HPLC column. Standard 
gradient conditions described above were employed to give N-(2-hydroxyphenyl)-acetamide (11) (0.3 mg) 
purified from fraction 5; diketopiperazines (3–8) were eluted in the same fractions as the mono-culture 
extract of Nocardiopsis sp.; the major induced compound, 1,6-dihydroxyphenazine (12) (5.9 mg), 
started to elute in fraction 24 and continued to elute off the column until fraction 42. Fractions 25 to 28 
were combined and re-run on a reverse-phase HPLC using Phenomenex Onyx Monolithic C18 column 
(10 mm × 100 mm) eluting with a gradient from H2O/MeOH (80:20 to 40:60 over 60 min) to purify 
compound 13a (0.6 mg). 
3.4. Bioactivity Testing 
3.4.1. Antibacterial Activity 
The induced compounds 11, 12 and 13a were tested for their antimicrobial activity using the 
standard disk diffusion assay against Bacillus sp. P25, Escherichia coli and Fusarium sp. P21, as well 
as the actinomycetes from where the compounds were derived, Nocardiopsis sp. RV163 and 
Actinokineospora sp. EG49. Sterile filter disks (6-mm diameter) loaded with the test compounds 
(25 μL of 1 mg/mL in methanol) were placed on agar plates that had been inoculated with 100 μL of 
the test microorganism (cultures with an optical density of OD600 = 0.2). After incubation (24 h for 
Bacillus, Escherichia coli and Fusarium sp. and 72 h for Nocardiopsis sp. RV163 and 
Actinokineospora sp. EG49) at 37 °C (Bacillus, Escherichia coli) and 30 °C (Fusarium sp., 
Nocardiopsis sp. RV163 and Actinokineospora sp. EG49), the antimicrobial potential was 
quantitatively assessed as the diameter of the inhibition zone (n = 2). 
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3.4.2. Anti-Trypanosomal Activity 
Anti-trypanosomal activity was tested following the protocol of Huber and Koella [44]. In complete 
Baltz medium, 10
4
 trypanosomes per millilitre of Trypanosoma brucei strain TC 221 were cultivated. 
Trypanosomes were tested in 96-well plate chambers against different concentrations of test 
substances at 0.25–40 μM in 1% DMSO to a final volume of 200 μL. For controls, 1% DMSO, as well 
as parasites without any test compounds were used simultaneously in each plate to show no effect of 
1% DMSO. The plates were then incubated at 37 °C in an atmosphere of 5% CO2 for 24 h. After the 
addition of 20 μL of Alamar Blue, the activity was measured after 48 and 72 h by light absorption using  
an MR 700 Microplate Reader at a wavelength of 550 nm with a reference wavelength of 650 nm.  
The IC50 value effect of the test compound was quantified by the linear interpolation of three 
independent measurements. 
The following equation was used to calculate IC50: 
log(IC50) = log(X1) + {[(Y1 − 0.5)/(Y1 − Y2)] × [log(X2) − log(X1)]} 
Y1 mean of the duplicate determination of the first measured cell density that is less than half the 
average of the growth control divided by the average of control growth. 
X1 concentration of the substance that belongs to the cell density of Y1. 
Y2 mean of the duplicate determination of the first measured cell density that is greater than half 
the average of the growth control divided by the average of control growth. 
X2 concentration of the substance that belongs to the cell density of Y2. 
3.4.3. Anti-Leishmanial Activity 
Anti-leishmanial activity was tested following the method of Ponte-Sucre et al. [45]. Briefly,  
10
7
 cells/mL Leishmania major promastigotes were incubated in complete medium for 24 h at 26 °C, 
5% CO2 and 95% humidity in the absence or presence of different concentrations of the test 
compounds (0.25–40 μM in 1% DMSO) to a final volume of 200 μL. Following the addition of 
Alamar Blue, the plates were incubated again, and the optical densities were determined after 48 h 
with a Multiskan Ascent enzyme-linked immunosorbent assay (ELISA) reader (Multiskan Ascent, 
Germany). The effects of cell density, incubation time and the concentration of DMSO were examined 
in control experiments. The results were expressed in IC50 values by linear interpolation of three 
independent experiments. 
3.5. Structure Elucidation of Compounds 1–13 
The structures of all known compounds were confirmed upon comparison of spectrometric  




C and 2D, where necessary) data with that of the 
published literature values. 
5a,6,11a,12-tetrahydro-5a,11a-dimethyl[1,4]benzoxazino[3,2-b][1,4]benzoxazine (13a): Yellow oil; 





NMR data in DMSO-d6 in good agreement with published values; 
1
H-NMR (pyridine-d5, 600 MHz) δ 
(J in Hz) 1.75 (s, 2CH3), 6.80 (t, 7.6, H-3/9), 6.90 (t, 7.6, H-2/8), 6.98 (d, 2H, H-4/10), 7.03 (d, 2H,  
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H-1/7), 8.00 (s, 2NH); 
13
C NMR (pyridine-d5, 125 MHz) 22.2 (2CH3), 83.5 (C-5a/11a), 115.5 (C-1/7), 
117.6 (C-4/10), 120.2 (C-3/9), 121.9 (C-2/8), 131.8 (C-6a/12a), 143.5 (C-4a/10a), LRESIMS m/z 




The genomes of microorganisms, particularly of the order, Actinomycetales, consist of a large 
number of putative biosynthetic gene clusters that encode for secondary metabolites that are not 
produced using standard fermentation protocols. To reach this cryptic treasure trove of natural products, 
approaches, such as co-cultivation, are required to induce them. In this study, two sponge-derived 
actinomycetes, Nocardiopsis sp. RV163 and Actinokineospora sp. EG49, were co-fermented in liquid 
media. The presence of induced metabolites was studied by comparison of the 
1
H-NMR fingerprints of 
the crude extracts of the two monocultures and the co-culture. The NMR fingerprint allowed the 
confidence of detecting all small molecules containing proton nuclei and was instrumental in 
demonstrating that the induced metabolites were co-culture specific and not present in either of the 
single cultures. Co-cultivation of Nocardiopsis sp. RV163 and Actinokineospora sp. EG49 induced the 
biosynthesis of three compounds, which were not detected in either microorganism in a single culture, 
namely N-(2-hydroxyphenyl)-acetamide (11), 1,6-dihydroxyphenazine (12) and 5a,6,11a,12-tetrahydro-5a, 
11a-dimethyl[1,4]benzoxazino[3,2-b][1,4]benzoxazine (13a). When tested for biological activity 
against a range of bacteria and parasites, only the phenazine, 12, was active against Bacillus sp. P25, 
Trypanosoma brucei and interestingly against Actinokineospora sp. EG49. Moreover, while not 
detectable by 
1
H-NMR in the monocultures, compound 12 was produced in a very high yield  
(12% crude weight) by the co-culture of the two microbes. These findings highlight the co-cultivation 
approach as an effective strategy to increase the yield of metabolites undetected in the single microbial 
culture and enhance the chemical diversity of the secondary metabolites hidden in the genomes of 
marine actinomycetes. 
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